Christopher Raymond
Stock Analyst at Piper Sandler
(0.88)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARDX Ardelyx | Maintains: Neutral | 8 9 | 5.4 | 66.67% | 9 | Aug 6, 2025 | |
ABVX Abivax | Maintains: Overweight | 42 70 | 69.02 | 1.42% | 2 | Jul 23, 2025 | |
BIIB Biogen | Maintains: Neutral | 135 115 | 128.03 | -10.18% | 17 | Apr 29, 2025 | |
ALXO ALX Oncology Holding... | Maintains: Overweight | 8 9 | 0.62 | 1351.61% | 6 | Mar 6, 2025 | |
BMRN Biomarin Pharmaceuti... | Maintains: Overweight | 122 126 | 56.8 | 121.83% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 4 | 1.79 | 123.46% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 109 119 | 129.46 | -8.08% | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 535 533 | 374.47 | 42.33% | 8 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 1195 1013 | 546.18 | 85.47% | 7 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 135 140 | 27.39 | 411.14% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 43 30 | 4 | 650% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 31.34 | 129.74% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 212 220 | 198.62 | 10.76% | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 3 13 | 1.64 | 692.68% | 2 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 75 | 3.73 | 1910.72% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 66 76 | 13.43 | 465.9% | 7 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 10 | 1.04 | 861.54% | 2 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 33 | 10.1 | 226.73% | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 7 | 2.75 | 154.55% | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 621 35 | 9.81 | 251.68% | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 18 23 | 25.59 | -10.12% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 4 | 2.65 | 50.94% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 | 10.93 | 101.28% | 1 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 2 4 | 3.35 | 19.4% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 17 | 16.87 | 0.77% | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 26 25 | 7.83 | 219.28% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 293 288 | 285.1 | 1.02% | 11 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 41 | 35.1 | 16.81% | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 2 | n/a | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 28 | 45.73 | -38.77% | 1 | Jul 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 12 | n/a | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 56 28 | 5.5 | 409.09% | 4 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 146 180 | 178.75 | 0.7% | 2 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | 74.98 | -46.65% | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 90 | 6.06 | 1385.15% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 3 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 35 | n/a | n/a | 1 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 20 | n/a | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 96 | 1.45 | 6520.69% | 2 | Mar 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 170 | 182.5 | -6.85% | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 133 | n/a | n/a | 2 | Oct 23, 2017 |